Sequoia Fund Reopens to New Investors After Plunge in AssetsBy
Valeant stock dive hurt results, reputation at storied fund
Sequoia will remain closed to those buying via third parties
Sequoia Fund, the Valeant Pharmaceuticals International Inc. holder whose assets fell as slumping performance led to outflows, is reopening to new investors.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.